HbA1c method performance: The great success story of global standardization

References

• Cho NH, Shaw JE, Karuranga S, et al. Diabetes Res Clin Pract. 2018;138:271–281.
   Google Scholar
• American Association of Clinical Endocrinologists Board of D, American College of Endocrinologists Board of T. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract. 2010;16:155–156.
   PubMed Web of Science ®Google Scholar
• Organization WH. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.
   Google Scholar
• John WG. Diabetes UKDoHACo. Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabet Med. 2012;29:1350–1357.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589.
   PubMed Web of Science ®Google Scholar
• Duckworth WC, Abraira C, Moritz TE, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications. 2011;25:355–361.
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.
   PubMed Web of Science ®Google Scholar
• Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–2128.
   PubMed Web of Science ®Google Scholar
• Hayward RA, Reaven PD, Wiitala WL, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;372:2197–2206.
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139.
   PubMed Web of Science ®Google Scholar
• Group AC, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.
   PubMed Web of Science ®Google Scholar
• Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311–322.
   PubMed Web of Science ®Google Scholar
• Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–1289.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Dia Care. 2015;38:140–149.
   PubMed Web of Science ®Google Scholar
• Weykamp CW, Mosca A, Gillery P, et al. The analytical goals for hemoglobin A(1c) measurement in IFCC units and National Glycohemoglobin Standardization Program Units are different. Clin Chem. 2011;57:1204–1206.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Petersen PH. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem. 1999;45:321–323.
   PubMed Web of Science ®Google Scholar
• Gill JP, Shephard MD. The conduct of quality control and quality assurance testing for PoCT outside the laboratory. Clin Biochem Rev. 2010;31:85–88.
   PubMedGoogle Scholar
• Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57:e1–e47.
   PubMed Web of Science ®Google Scholar
• Weykamp C, John G, Gillery P, et al. Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics. Clin Chem. 2015;61:752–759.
   PubMed Web of Science ®Google Scholar
• DG B. Quality control and quality assurance in point-of-care testing. In: CP SJA, Hicks JM, editor. Point-of-care testing. 2nd ed. Washington (DC): AACC Press; 2004. p. 137–45.
   Google Scholar
• Martin CL. Quality control issues in point of care testing. Clin Biochem Rev. 2008;29(1):S79–S82.
   Google Scholar
• Miller WG, Myers GL, Gantzer ML, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem. 2011;57:1108–1117.
   PubMed Web of Science ®Google Scholar
• Khera PK, Smith EP, Lindsell CJ, et al. Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation. Am J Hematol. 2015;90:50–55.
   PubMed Web of Science ®Google Scholar
• Jaisson S, Leroy N, Meurice J, et al. First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis. Clin Chem Lab Med. 2012;50:1769–1775.
   PubMed Web of Science ®Google Scholar
• John WG, Little R, Sacks DB, et al. Multicentre evaluation of the Premier Hb9210 HbA1c analyser. Clin Chem Lab Med. 2015;53:319–327.
   PubMed Web of Science ®Google Scholar
• Fleming JK. Evaluation of HbA1c on the Roche COBAS Integra 800 closed tube system. Clin Biochem. 2007;40:822–827.
   PubMed Web of Science ®Google Scholar
• Lenters-Westra E, English E. Evaluating new HbA1c methods for adoption by the IFCC and NGSP reference networks using international quality targets. Clin Chem Lab Med. 1426;55:34.
   Google Scholar
• Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009;3:446–451.
   PubMedGoogle Scholar
• Weykamp CW, Penders TJ, Muskiet FA, et al. Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods. Clin Chem. 1993;39:1717–1723.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, Connolly SM, England JD, et al. The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 2008;129:811–814.
   PubMed Web of Science ®Google Scholar
• NGSP. HbA1c Assay Interferences 2017. Available from: http://www.ngsp.org/interf.asp
   Google Scholar
• Institute CLS. Evaluation of precision performance of clinical chemistry devices; Approved guideline. NCCLS Document EP05-A. Wayne (PA): CLSI; 1992.
   Google Scholar
• Institute CaLS. Method comparison and bias estimation using patient samples; approved guideline. CLSI Document EP09-A. Wayne (PA): CLSI; 1995.
   Google Scholar
• Institute CaLS. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI Document EP06-a. Wayne (PA): CLSIe; 2003.
   Google Scholar
• Kaiser P, Spannagl M, van Campenhout C, et al. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system. Clin Chem Lab Med. 2016;54:1769–1775.
   PubMed Web of Science ®Google Scholar
• Mosca A, Paleari R, Carobene A, et al. Performance of glycated hemoglobin (HbA(1c)) methods evaluated with EQAS studies using fresh blood samples: Still space for improvements. Clin Chim Acta. 2015;451:305–309.
   PubMed Web of Science ®Google Scholar
• Thelen MHM, Jansen RTP, Weykamp CW, et al. Expressing analytical performance from multi-sample evaluation in laboratory EQA. Clin Chem Lab Med. 2017;55:1509–1516.
   PubMed Web of Science ®Google Scholar
• Weykamp C, Siebelder C. Evaluation of performance of laboratories and manufacturers within the framework of the IFCC model for quality targets of HbA1c. J Diabetes Sci Technol. 2017;193229681774132.
   Google Scholar
• Biochemists AAoC.PoCT. 2016. [04/05/16]. Available from: http://www.aacb.asn.au/resources/poct
   Google Scholar
• Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56:44–52.
   PubMed Web of Science ®Google Scholar
• Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014;60:1062–1072.
   PubMed Web of Science ®Google Scholar
• Schaffert L, English E, Heneghan C, et al. 2016. Horizon Scan 0044 Point-of-Care HbA1c tests - diagnosis of diabetes Oxford2016. Available from: http://www.oxford.dec.nihr.ac.uk/reports-and-resources/horizon-scanning-reports/point-of-care-hba1c-tests-diagnosis-of-diabetes
   Google Scholar
• Hirst JA, McLellan JH, Price CP, et al. Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis. Clin Chem Lab Med. 2017;55:167–180.
   PubMed Web of Science ®Google Scholar
• Misra S, John WG, Alberti G, et al. The use of POCT HbA1c devices in the NHS Diabetes Prevention Programme: recommendations from an expert working group commissioned by NHS England, NHS (Commissioned report). NHS England, 2016.
   Google Scholar
• Hub ESIRMM. Catalogue of reference materials. 2016. Available from: https://ec.europa.eu/jrc/sites/jrcsh/files/rm_catalogue_0.pdf
   Google Scholar
• John WG. Glycated haemoglobin analyses–assessment of within- and between-laboratory performance in a large UK region. Ann Clin Biochem. 1987;24:453–460.
   PubMed Web of Science ®Google Scholar
• Peterson CM, Jovanovic L, Raskin P, et al. A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards. Diabetologia. 1984;26:214–217.
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem. 1987;33:2267–2271.
   PubMed Web of Science ®Google Scholar
• Little RR, Rohlfing CL, Wiedmeyer HM, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem. 2001;47:1985–1992.
   PubMed Web of Science ®Google Scholar
• NGSP Network Laboratory Members. 2016. Available from: http://http://www.ngsp.org/network.asp
   Google Scholar
• College of American Pathology External Quality Scheme for HbA1c. 2016. [December 2016]. Available from: http://www.ngsp.org/CAP/CAP16c.pdf
   Google Scholar
• Shima K, Endo J, Oimomi M, et al. Interlaboratory difference in GHb measurement in Japan. The fifth report of the GHb standardization committee, the Japan diabetes society. J Japan Diab Soc. 1998;41:317–323.
   Google Scholar
• Jeppsson JO, Jerntorp P, Sundkvist G, et al. Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem. 1986;32:1867–1872.
   PubMed Web of Science ®Google Scholar
• Tominaga M, Makino H, Yoshino G, et al. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem. 2005;42:41–46.
   PubMed Web of Science ®Google Scholar
• Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1:212–228.
   PubMed Web of Science ®Google Scholar
• Standardization IOf. ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems. Available from: https://www.iso.org/committee/54916.html
   Google Scholar
• Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA(1c) in human blood. Clin Chem Lab Med. 2002;40:78–89.
   PubMed Web of Science ®Google Scholar
• Approved laboratories of the IFCC network laboratories for HbA1c. 2016. [December 2016]. Available from: www.ifcchba1c.net/network/approved
   Google Scholar
• Weykamp C, John WG, Mosca A, et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem. 2008;54:240–248.
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Rigby AS, Atkin SL, et al. Glycemic control in the 12 months following a change to SI hemoglobin A1c reporting units. Clin Chem. 2013;59:1457–1460.
   PubMed Web of Science ®Google Scholar
• Geistanger A, Arends S, Berding C, et al. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem. 2008;54:1379–1385.
   PubMed Web of Science ®Google Scholar
• Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50:166–174.
   PubMed Web of Science ®Google Scholar
• NGSP. Convert between NGSP, IFCC and eAG. 2010. Available from: http://www.ngsp.org/convert1.asp
   Google Scholar
• International Federation Of Clinical C, Laboratory Medicine ISD, Nordin G. Dybkaer R. Recommendation for term and measurement unit for “HbA1c”. Clin Chem Lab Med. 2007;45:1081–1082.
   PubMed Web of Science ®Google Scholar
• Lenters-Westra EE. Understanding the use of sigma metrics in hemoglobin A1c analysis. Clin Lab Med. 2016;37:57–71.
   Google Scholar
• Hanas R, John G, International Hb ACC. 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Clin Chem. 2010;56:1362–1364.
   PubMed Web of Science ®Google Scholar
• Borg R, Kuenen JC, Carstensen B, et al. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes. 2010;59:1585–1590.
   PubMed Web of Science ®Google Scholar
• Malka R, Nathan DM, Higgins JM. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med. 2016;8:359ra130.
   PubMed Web of Science ®Google Scholar
• English E, Idris I, Smith G, et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58:1409–1421.
   PubMed Web of Science ®Google Scholar